AUGO (NASDAQ: AUGO) investor files to sell 50,000 common shares

Rhea-AI Filing Summary

AUGO shareholder Glauber Rosa Luvizotto filed to sell up to 50,000 common shares through broker Merrill Lynch Pierce Fenner & Smith. The shares relate to a stock option exercise for cash dated 12/17/2024. The filing lists an aggregate market value of $3,504,951.50 and notes 83,789,223 common shares outstanding on Nasdaq. Recent sales over the past three months include several transactions ranging from 2,300 to 22,367 shares.

Key Figures

Shares to be sold: 50,000 shares Aggregate market value: $3,504,951.50 Shares outstanding: 83,789,223 shares +4 more

7 metrics

Shares to be sold 50,000 shares Planned sale of common shares via Merrill Lynch

Aggregate market value $3,504,951.50 Value associated with the 50,000 common shares

Shares outstanding 83,789,223 shares Common shares outstanding on Nasdaq

Sale 1 6,323 shares; $412,407.36 Common shares sold on 06/22/2026

Sale 2 22,367 shares; $1,459,835.47 Common shares sold on 06/26/2026

Sale 3 2,300 shares; $149,501 Common shares sold on 07/01/2026

Sale 4 19,010 shares; $1,240,016.98 Common shares sold on 07/02/2026

Key Terms

Common shares, Stock option exercise, Cash

3 terms

Common shares financial

"Common shares | Merrill Lynch Pierce Fenner & Smith 19495 Biscayne Blvd."

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

Stock option exercise financial

"Common shares | 12/17/2024 | Stock option exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Cash financial

"50000 | 12/17/2024 | Cash"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 04:19 PM Accepted by SEC EDGAR 08/07/2026 - 04:19 PM Learn about SEC filing dates

FAQ

What share sale is disclosed for AUGO in this Form 144?

The filing discloses a planned sale of up to 50,000 common shares of AUGO. These shares are associated with a stock option exercise and are to be sold through Merrill Lynch Pierce Fenner & Smith on Nasdaq.

How will the 50,000 AUGO shares be acquired before sale?

The 50,000 AUGO shares are tied to a stock option exercise dated 12/17/2024. The filing states the acquisition method as a stock option exercise from the issuer, with the form of payment listed as cash.

What market value and share count does the AUGO Form 144 reference?

The Form 144 references an aggregate market value of $3,504,951.50 for the 50,000 common shares and notes 83,789,223 AUGO common shares outstanding, traded on the Nasdaq market.

Which broker is handling the proposed AUGO share sale?

The proposed sale of 50,000 AUGO common shares will be handled by Merrill Lynch Pierce Fenner & Smith, located at 19495 Biscayne Blvd., Suite 700, Aventura, FL 33180, according to the Form 144 disclosure.

What recent AUGO share sales by Glauber Rosa Luvizotto are reported?

Recent sales listed include 6,323 shares on 06/22/2026, 22,367 shares on 06/26/2026, 2,300 shares on 07/01/2026, and 19,010 shares on 07/02/2026, each with corresponding dollar amounts disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common shares	Merrill Lynch Pierce Fenner & Smith 19495 Biscayne Blvd. Suite 700 Aventura FL 33180	50000	3504951.5	83789223	08/07/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common shares	12/17/2024	Stock option exercise	Issuer			50000	12/17/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Glauber Rosa Luvizotto 3309 Mary Street - suite 116 Coconut Grove FL 33134	Common	06/22/2026	6323	412407.36
Glauber Rosa Luvizotto 3309 Mary Street - suite 116 Coconut Grove FL 33134	Common	06/26/2026	22367	1459835.47
Glauber Rosa Luvizotto 3309 Mary Street - suite 116 Coconut Grove FL 33134	Common	07/01/2026	2300	149501
Glauber Rosa Luvizotto 3309 Mary Street - suite 116 Coconut Grove FL 33134	Common	07/02/2026	19010	1240016.98

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)